ETENDERS

Contract notice

Information

Published

Date of dispatch of this notice: 20/04/2018

Expire date: 30/05/2018

External Reference: 2018-086343

TED Reference: 2018/S 079-176043

Contract notice

Contract notice

Directive 2014/24/EU

Section I: Contracting authority

I.1)

Name and addresses

Our Lady's Children's Hospital, Crumlin
N/A
Dublin 12
Dublin
Ireland
IE
Contact person: robert keogh
Telephone: +353 014096598
E-mail: robert.keogh@olhsc.ie
NUTS code:  IE -  IRELAND
Internet address(es):
Main address: http://www.olchc.ie
Address of the buyer profile: https://irl.eu-supply.com/ctm/Company/CompanyInformation/Index/384

I.3)

Communication

The procurement documents are available for unrestricted and full direct access, free of charge, at:  
http://irl.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=126683&B=ETENDERS_SIMPLE
Additional information can be obtained from
the abovementioned address:  
Tenders or requests to participate must be submitted
to the abovementioned address
I.4)

Type of the contracting authority

Body governed by public law
I.5)

Main activity

Health

Section II: Object

II.1)

Scope of the procurement

II.1.1)

Title

Supply of Infliximab or biosimilar
II.1.2)

Main CPV code

33600000  -  Pharmaceutical products
II.1.3)

Type of contract

Supplies
II.1.4)

Short description

To appoint a single provider for the provision, supply, support and delivery of Infliximab or Infliximab biosimilar to patients in Our Lady’s Children’s Hospital Crumlin (OLCHC). It is envisaged that Infliximab-naïve patients in OLCHC will receive the tendered product initially with a view to switch all existing patients within 6 months.
II.1.5)

Estimated total value

Value excluding VAT: 1.00  EUR
II.1.6)

Information about lots

This contract is divided into lots: no
II.2)

Description

II.2.2)

Additional CPV code(s)

33600000  -  Pharmaceutical products
II.2.3)

Place of performance

NUTS code:  IE -  IRELAND
Main site or place of performance:  
Our Lady's Children's Hospital, Crumlin
II.2.4)

Description of the procurement

To appoint a single provider for the provision, supply, support and delivery of Infliximab or Infliximab biosimilar to patients in Our Lady’s Children’s Hospital Crumlin (OLCHC). It is envisaged that Infliximab-naïve patients in OLCHC will receive the tendered product initially with a view to switch all existing patients within 6 months.
II.2.5)

Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6)

Estimated value

Value excluding VAT: 1.00  EUR
II.2.7)

Duration of the contract, framework agreement or dynamic purchasing system

Duration in months: 36
This contract is subject to renewal: yes
Description of renewals:  
The contract will be for an initial 12 month period with an option to extend to 36 months subject to satisfactory performance. The Hospital reserves the right to seek a review in the event of an increase in usage.
II.2.10)

Information about variants

Variants will be accepted: yes
II.2.11)

Information about options

Options: no
II.2.13)

Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: no

Section III: Legal, economic, financial and technical information

III.1)

Conditions for participation

III.1.1)

Suitability to pursue the professional activity, including requirements relating to enrolment on professional or trade registers

List and brief description of conditions:  Must be licensed for use in the Republic of Ireland (ROI) by the Health Products Regulatory Authority (HPRA).
Published data on the use of infliximab or biosimilar infliximab in the paediatric population must be supplied if applicable.
III.1.2)

Economic and financial standing

Selection criteria as stated in the procurement documents
III.1.3)

Technical and professional ability

Selection criteria as stated in the procurement documents
III.2)

Conditions related to the contract

Section IV: Procedure

IV.1)

Description

IV.1.1)

Type of procedure

Open procedure
IV.1.8)

Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement : no
IV.2)

Administrative information

IV.2.2)

Time limit for receipt of tenders or requests to participate

Date:  27/04/2018
Local time:  12:00
IV.2.4)

Languages in which tenders or requests to participate may be submitted

English
IV.2.6)

Minimum time frame during which the tenderer must maintain the tender

Duration in months : 36  (from the date stated for receipt of tender)
IV.2.7)

Conditions for opening of tenders

Date:  27/04/2018
Local time:  12:00
Place:  
Our Lady's Children's Hospital, Crunlin

Section VI: Complementary information

VI.1)

Information about recurrence

This is a recurrent procurement:  no
VI.2)

Information about electronic workflows

Electronic ordering will be used
Electronic invoicing will be accepted
Electronic payment will be used
VI.4)

Procedures for review

VI.4.1)

Review body

High Court
Inns Quay
Dublin
7
IE